Goldman Sachs Slashes PT on Edwards Lifesciences (EW), Maintains Buy
Tweet Send to a Friend
Goldman Sachs maintained a Buy rating on Edwards Lifesciences (NYSE: EW) but cut its price target to $107.00 (from $121.00) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
